Article Versions Notes

Lee J, Han J-W, Sung P-S, Lee S-K, Yang H, Nam H-C, Yoo S-H, Lee H-L, Kim H-Y, Lee S-W, et al. Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study. Journal of Clinical Medicine. 2021; 10(18):4045. https://doi.org/10.3390/jcm10184045

Lee, Jaejun, Ji-Won Han, Pil-Soo Sung, Soon-Kyu Lee, Hyun Yang, Hee-Chul Nam, Sun-Hong Yoo, Hae-Lim Lee, Hee-Yeon Kim, Sung-Won Lee, and et al. 2021. "Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study" Journal of Clinical Medicine 10, no. 18: 4045. https://doi.org/10.3390/jcm10184045

Lee, J., Han, J.-W., Sung, P.-S., Lee, S.-K., Yang, H., Nam, H.-C., Yoo, S.-H., Lee, H.-L., Kim, H.-Y., Lee, S.-W., Kwon, J.-H., Jang, J.-W., Kim, C.-W., Nam, S.-W., Oh, J.-S., Chun, H.-J., Bae, S.-H., Choi, J.-Y., & Yoon, S.-K. (2021). Comparative Analysis of Lenvatinib and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma: A Multi-Center, Propensity Score Study. Journal of Clinical Medicine, 10(18), 4045. https://doi.org/10.3390/jcm10184045